301 related articles for article (PubMed ID: 34489848)
1. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
Garza M; Piquet AL
Front Neurol; 2021; 12():683048. PubMed ID: 34489848
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune Vestibulocerebellar Syndromes.
Narayan RN; McKeon A; Fife TD
Semin Neurol; 2020 Feb; 40(1):97-115. PubMed ID: 31958862
[TBL] [Abstract][Full Text] [Related]
3. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
[TBL] [Abstract][Full Text] [Related]
4. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
5. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
6. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
7. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
8. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune movement disorders with neuronal antibodies - an update.
Balint B; Bhatia KP
Curr Opin Neurol; 2021 Aug; 34(4):565-571. PubMed ID: 34010219
[TBL] [Abstract][Full Text] [Related]
10. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
11. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.
Greenlee JE; Brashear HR
Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.
Dropcho EJ
Ann Neurol; 1995 May; 37 Suppl 1():S102-13. PubMed ID: 8968221
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2.
Ruiz-García R; Martínez-Hernández E; Joubert B; Petit-Pedrol M; Pajarón-Boix E; Fernández V; Salais L; Del Pozo M; Armangué T; Sabater L; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31826987
[TBL] [Abstract][Full Text] [Related]
14. Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review.
Mange L; Haitao R; Lixin Z; Siyuan F; Jing W; Hongzhi G
J Neurol; 2021 Nov; 268(11):4163-4169. PubMed ID: 33988764
[TBL] [Abstract][Full Text] [Related]
15. Anti-Homer-3 antibodies in cerebrospinal fluid and serum samples from a 58-year-old woman with subacute cerebellar degeneration and diffuse breast adenocarcinoma.
Klötzsch C; Böhmert M; Hermann R; Teegen B; Rentzsch K; Till A
Neurol Res Pract; 2022 Jul; 4(1):29. PubMed ID: 35871640
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
17. Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia.
Miske R; Scharf M; Borowski K; Rieckhoff N; Teegen B; Denno Y; Probst C; Guthke K; Didrihsone I; Wildemann B; Ruprecht K; Komorowski L; Jarius S
J Neuroinflammation; 2023 Mar; 20(1):88. PubMed ID: 36997937
[TBL] [Abstract][Full Text] [Related]
18. Anti-SEZ6L2 antibodies in paraneoplastic cerebellar syndrome: case report and review of the literature.
Kather A; Holtbernd F; Brunkhorst R; Hasan D; Markewitz R; Wandinger KP; Wiesmann M; Schulz JB; Tauber SC
Neurol Res Pract; 2022 Oct; 4(1):54. PubMed ID: 36310162
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic autoimmune movement disorders.
Lim TT
Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
